Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
Health Management AssociatesMarch 12, 2026

New Federal PBM Transparency Rules Signal Broader Oversight Trend

The piece reviews early 2026 federal actions tightening oversight of pharmacy benefit managers, including new DOL disclosure rules, the Consolidated Appropriations Act of 2026's transparency and compensation restrictions for Medicare Part D, and an FTC settlement with Express Scripts. While the analysis centers on commercial insurance and Medicare Part D, the compensation and contracting reforms described are relevant to Medicaid managed care plans that rely on PBM arrangements and may face similar transparency pressures as CMS implementation unfolds.

Pharmacy · Managed Care

Read the full analysis at Health Management Associates →

This is outside commentary from Health Management Associates, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Health Management Associates

← Analysis & Perspectives

Get the daily briefing.